Healthy individuals E10.9 E11.9
Conditions
Interventions
Group 1: A blood sample is taken by venipuncture and the medical history of the study participants is recorded. The studyparticipants have to come to the clinic only once.
Sponsors
Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Endokrinologie und Diabetologie
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Male or female, aged 18-90 years (both inclusive); 2. Diagnosed with type 1 diabetes or type 2 diabetes; For healthy study participants: 1. Male or female, aged 18-90 years (both inclusive)
Exclusion criteria
Exclusion criteria: 1. Any disorder, except for conditions associated with diabetes, which in the investigator’s opinion might jeopardise subject’s safety or results. For healthy study participants: 1. Diabetes mellitus or known conditions that affect glucagon concentration like Roux-en-Y-Gastric bypass, vagotomy or renal failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study was to determine fasting glucagon values ??of individuals with type 1 diabetes and type 2 diabetes in comparison to healthy study participants. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of two glucagon analysis methods in healthy people and in individuals with type 1 diabetes and type 2 diabetes. | — |
Countries
Austria
Contacts
Public ContactMartina Brunner
Medizinische Universität Graz, Zentrum für medizinische Forschung, CF-Clinical Trials Unit
Outcome results
None listed